312 related articles for article (PubMed ID: 8311535)
1. Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients.
Koh ET; Seow A; Ong B; Ratnagopal P; Tjia H; Chng HH
Ann Rheum Dis; 1993 Dec; 52(12):857-61. PubMed ID: 8311535
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
So MW; Koo BS; Kim YG; Lee CK; Yoo B
J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors.
Ishizuka M; Watanabe R; Ishii T; Machiyama T; Akita K; Fujita Y; Shirota Y; Fujii H; Harigae H
Mod Rheumatol; 2016; 26(1):115-20. PubMed ID: 26011440
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of dermatomyositis and polymyositis: a study of 102 cases.
Scola RH; Werneck LC; Prevedello DM; Toderke EL; Iwamoto FM
Arq Neuropsiquiatr; 2000 Sep; 58(3B):789-99. PubMed ID: 11018813
[TBL] [Abstract][Full Text] [Related]
5. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667
[TBL] [Abstract][Full Text] [Related]
6. Features of polymyositis and dermatomyositis in the elderly: a case-control study.
Pautas E; Chérin P; Piette JC; Pelletier S; Wechsler B; Cabane J; Herson S
Clin Exp Rheumatol; 2000; 18(2):241-4. PubMed ID: 10812498
[TBL] [Abstract][Full Text] [Related]
7. Polymyositis: an overdiagnosed entity.
van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary involvement in polymyositis and in dermatomyositis.
Marie I; Hatron PY; Hachulla E; Wallaert B; Michon-Pasturel U; Devulder B
J Rheumatol; 1998 Jul; 25(7):1336-43. PubMed ID: 9676766
[TBL] [Abstract][Full Text] [Related]
9. Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study.
Danieli MG; Gambini S; Pettinari L; Logullo F; Veronesi G; Gabrielli A
Autoimmun Rev; 2014 Oct; 13(10):1048-54. PubMed ID: 25183232
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909
[TBL] [Abstract][Full Text] [Related]
11. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
[TBL] [Abstract][Full Text] [Related]
12. An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis.
Huang ZG; Gao BX; Chen H; Yang MX; Chen XL; Yan R; Lu X; Shi KN; Chan Q; Wang GC
PLoS One; 2017; 12(7):e0181069. PubMed ID: 28715432
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort.
Dobloug C; Garen T; Bitter H; Stjärne J; Stenseth G; Grøvle L; Sem M; Gran JT; Molberg Ø
Ann Rheum Dis; 2015 Aug; 74(8):1551-6. PubMed ID: 24695011
[TBL] [Abstract][Full Text] [Related]
15. Prognosis and mortality of polymyositis and dermatomyositis patients.
Airio A; Kautiainen H; Hakala M
Clin Rheumatol; 2006 Mar; 25(2):234-9. PubMed ID: 16477398
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF
Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973
[TBL] [Abstract][Full Text] [Related]
17. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.
Chen YJ; Wu CY; Shen JL
Br J Dermatol; 2001 Apr; 144(4):825-31. PubMed ID: 11298544
[TBL] [Abstract][Full Text] [Related]
18. Malignancies in Korean patients with inflammatory myopathy.
Lee SW; Jung SY; Park MC; Park YB; Lee SK
Yonsei Med J; 2006 Aug; 47(4):519-23. PubMed ID: 16941742
[TBL] [Abstract][Full Text] [Related]
19. High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis.
Maoz CR; Langevitz P; Livneh A; Blumstein Z; Sadeh M; Bank I; Gur H; Ehrenfeld M
Semin Arthritis Rheum; 1998 Apr; 27(5):319-24. PubMed ID: 9572713
[TBL] [Abstract][Full Text] [Related]
20. Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options.
Fredi M; Bartoli F; Cavazzana I; Ceribelli A; Carabellese N; Tincani A; Satoh M; Franceschini F
Clin Exp Rheumatol; 2017; 35(2):303-308. PubMed ID: 27908312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
